The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,226.00
Bid: 1,226.00
Ask: 1,228.00
Change: 13.00 (1.07%)
Spread: 2.00 (0.163%)
Open: 1,201.00
High: 1,235.00
Low: 1,201.00
Prev. Close: 1,213.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Proposed NYSE Listing

29 Sep 2020 07:00

RNS Number : 3681A
Burford Capital Limited
29 September 2020
 

 

 

29 September 2020

 

 

BURFORD ANNOUNCES UPDATE ON PROPOSED NYSE LISTING

 

Burford expands investor relations function

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today announced that the US Securities and Exchange Commission ("SEC") has completed its review of Burford's Form 20-F registration statement.

 

As previously noted, some administrative and mechanical matters will now need to occur prior to the commencement of trading of Burford's ordinary shares on the New York Stock Exchange ("NYSE"), in addition to continuing trading on London Stock Exchange AIM. Burford will shortly communicate with shareholders about those matters. Once they are complete, it is anticipated that trading on the NYSE will commence on Monday 19 October.

 

In anticipation of the US listing, Burford has expanded its investor relations function.

 

·

Robert Bailhache, who has been with Burford full-time since September 2019 and has been a close external adviser since Burford's IPO in 2009, will become Head of Investor Relations, EMEA and Asia, based in London

·

James Ballan has joined Burford as Head of Investor Relations, Americas, based in New York. Mr. Ballan has a decade of senior IR experience at specialty finance firms, most recently as Director, Investor Relations at CIT Group (NYSE: CIT), and has a further 20 years of Wall Street experience in banking and as a senior sell-side research analyst

·

Brian Tracy, who has been with Burford since 2017, continues to run Burford's private funds IR function as Head of Investor Relations, Private Funds, based in Chicago

 

Christopher Bogart, CEO of Burford, commented:

"Today marks a significant step in Burford's evolution, as well as proving our leadership in the further institutionalisation of legal finance in global capital markets. We expect our US listing to create a positive symbiosis for our business, serving to increase the pool of investors able to invest in Burford's shares while also more broadly raising our profile in the US capital markets. In time, both these developments may lower Burford's cost of capital. Furthermore, as the first legal finance firm to list its shares on a US stock exchange and become subject to NYSE and SEC regulation, we are choosing to submit ourselves, corporately and individually, to the rigour of the world's most well-regarded securities regulatory framework."

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

 

For further information, please contact:

 

Burford Capital Limited

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Huw Jeremy (NOMAD)

Charlie Farquhar / Jonathan Abbott (Joint Broker)

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRLPMMTMTITTPM
Date   Source Headline
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares
7th Jun 20223:00 pmRNSNotification of Major Holdings
1st Jun 20223:00 pmRNSRetail Shareholder Call Registration Details
1st Jun 202210:00 amRNSSterling FX Rate for 2021 Final Dividend
26th May 202212:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSExtension of SWF Arrangement & Fund Management
25th May 20227:00 amRNSPurchases of Shares for Employee Compensation Plan
24th May 20223:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.